Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-02-18FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for enalapril maleate from Northstar RxLLC. The approval confirms changes associated with this gener…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Cardiac and Renal Disease Study (CARDS)
This document reports the completion of the CARDS trial evaluating atorvastatin in individuals with diabetes at risk for cardiovascular dise…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Prevention of Early Readmission in Elderly Congestive Heart Failure Patients [Phase 2]
A Phase 2 trial sponsored by NHLBI evaluating strategies to prevent early readmission in elderly patients with congestive heart failure has …
-
FDA approval · 2016-02-18FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories. The action updates the drug’s labeling.
-
FDA approval · 2016-02-18FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Enalapril Maleate from Northstar RxLLC under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
An NHLBI-sponsored clinical trial update summarizes lifetime risk estimates for cardiovascular disease among non-white ethnic groups from a …
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Congestive Heart Failure Trends in the Elderly 1970-94
This clinical trial update examines trends in congestive heart failure among elderly individuals from 1970 to 1994, based on NHLBI-sponsored…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Long-Term Predictors of Morbidity in Older Age
The NHLBI-sponsored clinical trial on long-term predictors of morbidity in older age has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: ESCAPE Mechanistic Substudies - Ancillary to ESCAPE
The ESCAPE mechanistic substudies, ancillary to the ESCAPE trial, have completed its mechanistic investigations under NHLBI oversight.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Telemonitoring and Teleintervention of Heart Failure and Decrease of Non-fatal Events. [NA]
A completed study evaluating telemonitoring and teleintervention to reduce non-fatal events in heart failure patients.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Intermittent Intravenous Levosimendan in Ambulatory Advanced Chronic Heart Failure Patients [Phase 4]
Phase 4 clinical trial assessing intermittent intravenous levosimendan in ambulatory patients with advanced chronic heart failure has comple…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Inspiratory Muscle Training in Patients With Chronic Heart Failure [NA]
A clinical trial evaluating inspiratory muscle training in patients with chronic heart failure has completed; no efficacy results are provid…
-
FDA approval · 2016-02-16FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Ramipril (generic ACE inhibitor) under ANDA 077626, enabling a generic …
-
FDA approval · 2016-02-16FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril) under an existing ANDA. The action confirms continue…
-
FDA approval · 2016-02-12FDA Approved: ENTRESTO — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for ENTRESTO (sacubitril and valsartan) from Novartis Pharmaceuticals, resulting in labeling updates…
-
CLINICAL_TRIALS research · 2016-02-12Clinical Trial Update: REmoTe TelenURsiNg on Lung Function of Heart Failure Outpatients [NA]
An update on a clinical trial evaluating remote telenursing to monitor lung function in outpatients with heart failure.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Identifying and Facilitating Ventricular Recovery on Mechanical Support
Clinical trial updating methods to identify and facilitate ventricular recovery for patients on mechanical support in heart failure.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Developing a Non-invasive Cardiac Functional Health Status Measurement Device [NA]
A terminated clinical trial update about developing a non-invasive device to measure cardiac functional health status in heart failure patie…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Intravenous Allopurinol in Heart Failure [Phase 2]
A Phase 2 study evaluating intravenous allopurinol in congestive heart failure has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: Correlation of Non-invasive Assessment, Using C.A 2.0 Device, Versus Invasive Assessment of LVEDP
A completed clinical trial evaluates how well a non-invasive CA 2.0 device correlates with the invasive measurement of left ventricular end-…
-
CLINICAL_TRIALS research · 2016-02-09Clinical Trial Update: Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research [Phase 1, Phase 2]
An update on a University of Alberta clinical trial evaluating multidisciplinary novel therapies for breast cancer and heart failure in Phas…
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: Telehealth Program in Chronic Patients [NA]
This ClinicalTrials.gov entry reports the completion of a telehealth program study in chronic patients with Chronic Obstructive Pulmonary Di…
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study
This entry notes a completed ancillary eye study for the Multi-Ethnic Study of Atherosclerosis (MESA), sponsored by the University of Wiscon…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Carbohydrate Antigen 125-guided Therapy in Heart Failure [Phase 4]
A Phase 4 trial investigating carbohydrate antigen 125-guided therapy for heart failure has completed; the update does not provide detailed …
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: FREEDOM - A Frequent Optimization Study Using the QuickOpt Method [NA]
A clinical trial update for the FREEDOM study shows the Frequent Optimization Using the QuickOpt Method has completed, with results posted i…